Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
The Bridge Program works in Biotechnology Research, out of Brisbane, QLD. Ownership is a partnership; it publishes at research.qut.edu.au. It holds one address on record, all in Australia. The record counts 7 people. Tagged commercialisation, medical and biotech. The record links five similar brands, most of them in Research Services.
The Bridge Program is convened and administered by Queensland University of Technology and involves a consortium of pharmaceutical companies, universities and industry associations with the aim to boost the commercial outputs of Australian pharmaceutical research, by improving the quality and quantity of commercial deals that arise from Australia’s pharmaceutical research sector.
The Bridge Program is supported by industry to deliver an exciting education program each year, providing the necessary training to enable successful commercialisation of Australian pharmaceutical research.
Launched in June 2017, the program selects 100 participants annually from across Australia to take part in face-to-face and online training in the scientific, legal, financial, clinical, regulatory and reimbursement disciplines that contribute to research translation and the commercialisation of medicines.
Program participants will also benefit from direct exposure to networking opportunities with top pharmaceutical companies operating globally.
The Bridge Program is unique in its integration into venture capital and global pharmaceutical networks and its ability to share specific, detailed and practical know-how that will assist researchers and entrepreneurs to improve the quality and quantity of leads that they could offer for development, and to accelerate the process of commercialisation.
The Bridge Program is specifically set up as a national, sector-wide program that will benefit a large number of participants and their organisations, particularly those from the SME sector. The program will not only benefit trainees, it will also improve the planning and execution of research & development in their organisations, and the networking opportunities available to them. This will ultimately deliver more advanced and commercially viable leads, better deal opportunities, and higher returns from Australian research.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
The record holds 7 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Brisbane, QLD 4000.
None linked to this brand.
11 tags on the brand's own list, among them commercialisation, medical and biotech.
10 profiles list The Bridge Program as a peer — 82nd percentile in Biotechnology Research. It lists ten peers of its own. QUT Centre for Genomics and Personalised Health and The BridgeTech Program list it back.